ClinicalTrials.gg
Not yet recruitingNCT07690033ADHD childrenUpdated Jul 13, 2026

Eating Behaviour and Snack Consumption Patterns Among Children With ADHD

An observational study in Attention Deficit and Hyperactivity Disorder (ADHD), sponsored by Sohag University. Not yet recruiting. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-13.

Sponsored by Sohag University · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
150
Ages
6 Years to 12 Years
Sex
All
01

Study summary

The goal of this observational study is to learn about the effect of eating behavior and snack consumption patterns among children with ADHD. The main question it aims to answer is:

Does snack consumption increase insidenc and severity of ADHD?? Participants will answer survey questions about their eating behavior and snack consumption patterns.

Read the detailed description

To investigate how beverage and snack consumption patterns and child eating behaviours differ between children with ADHD and matched healthy controls and explore the association between these patterns and ADHD status among children attending Sohag University Hospital.

02

Conditions studied

  • Attention Deficit and Hyperactivity Disorder (ADHD)

Keywords

  • Snack consumption
  • Eating behaviour
  • ADHD
03

In context

Attention Deficit Disorder with Hyperactivity

1,817 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 296 are open to participants now.

This study's planned enrollment of 150 is above the median of 127 across 329 observational studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Cases: All eligible children (total coverage) aged 6-12 years attending Child Psychiatry/Pediatrics clinic and diagnosed with ADHD during the study period

Controls: ADHD free children attending outpatient/general pediatric clinic , matched to cases by age and sex in a 2:1 control: case ratio

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 6-12 years.
  • Met the diagnostic criteria for ADHD by the 5th edition of the (DSM-5); and severity assessment by Conners Rating Scale (parent form)
  • For controls: negative ADHD assessment using DSM 5 clinical interview and Conners scale; no history of ADHD diagnosis

Exclusion criteria

Exclusion Criteria:

  • ADHD symptoms due to other neurodevelopmental, psychotic, mood or organic disorders, or medication effects
  • Known neurological disease, severe chronic illness, or special diet that may alter intake
  • Use of psychotropic or appetite altering medications for ≥3 months
  • Refusal to participate
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
150 participants (estimated)
Patient registry
No

Interventions

  • OtherSelf administered questionnaire

    • The Child Eating Behavior Questionnaire (CEBQ). and Beverage and snack questionnaire to asses eating behavior and snack consumption patterns among children with ADHD

06

What researchers measure

Primary outcomes

  1. Child eating behavior score

    a 35-item assessing eating style in children. Eating style is assessed on eight scales: food responsiveness (4 items), enjoyment of food (4 items), emotional overeating (4 items), desire to drink (3 items), satiety responsiveness (5 items), slowness in eating (4 items), and emotional undereating (4 items), and fussiness (7 items). Informants rate the frequency of their child's behaviors and experiences on a 5-point scale: 1 = never, 2 = rarely, 3 = sometimes, 4 = often, 5 = always

    Time frame: Baseline (at a single piont during questionnaire administration)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Feb 2027, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 1, 2026
First posted
Jul 8, 2026
StartEst.
Aug 1, 2026
Primary completionEst.
Feb 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Jul 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07690033
Lead sponsor
Sohag University
Responsible party
Zahraa Aboelfottoh Metawee (Demonstrator of family medicine, Sohag University) — Principal investigator
First posted
Jul 8, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Jul 13, 2026

Study contacts

Zahraa Aboelfotoh Motawee demonstrator, Master
Contact
Zahraa.Metawee@med.sohag.edu.eg
+201121292982 ext. +201019278992

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion